Frontlight ResearchEarly access
Trial site
Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Pfizer2 trials
- Anbogen Therapeutics, Inc.1 trial
- Celldex Therapeutics1 trial
- ModernaTX, Inc.1 trial
- and 1 more
Running trials
Enrolling by invitation
Recruiting
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria2 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026